DUBLIN, Aug. 10, 2022 /PRNewswire/ — The ‘Global Wind Turbine Market: Analysis By Location, By Axis, By Component, By Application, By Region, Size and Trends with Impact of COVID-19 and Forecast up to 2026’ report has been added to ResearchAndMarkets.com’s offering. The global wind…
Related Posts
City of Lancaster Mayor Addresses Government and Business Leaders in Tokyo
Mayor R. Rex Parris shared the lessons learned from the City’s effort to achieve net-zero in 2019 and to become…
Kokam fortalece la oferta de almacenamiento de baterías marítimas con la aprobación DNV 2021
SEÚL, Corea, 4 de julio de 2022 /PRNewswire/ — Kokam Limited Company, proveedor global de soluciones innovadoras de baterías lithium…
Alembic Pharmaceuticals receives USFDA Tentative Approval for Ivabradine Tablets, 5 mg and 7.5 mg.
Pharma Desk, India: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Ivabradine Tablets, 5 mg and 7.5 mg. The tentatively approved ANDA is therapeutically equivalent to the reference listed drug product (RLD) Corlanor Tablets, 5…
Read More “Alembic Pharmaceuticals receives USFDA Tentative Approval for Ivabradine Tablets, 5 mg and 7.5 mg.” »
The post Alembic Pharmaceuticals receives USFDA Tentative Approval for Ivabradine Tablets, 5 mg and 7.5 mg. appeared first on NEWSX 360 : The Global News Platform.